Amphastar’s “Vision for the Future” is to be an industry leader in the development, manufacture, and marketing of injectable, intranasal and inhalation pharmaceutical products. We will continue to manufacture and distribute high quality products in an efficient manner so that we can offer them to the consumer at competitive, yet affordable prices.
Clearly understanding what it will take to achieve this vision, Amphastar will remain vigilant in its investment in new R&D, the expansion of its current injectables and inhalation lines, and making improvements to its delivery systems and dosage forms for existing products. Additionally, Amphastar is currently developing biosimilars to three different insulin products.
In the area of new products, we will target better drugs for the diseases that plague our aging population such as Alzheimer's disease, asthma, diabetes and osteoporosis.
Amphastar intends to continue to invest in its people by providing educational opportunities for advanced degrees and individual skills training to ensure that the highest standards in quality pharmaceutical manufacturing and technology are not just met but exceeded.